OncoCELL

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameOncoCELL
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsKidney NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiomira USA Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomira USA Inc
Active IndicationsN/A
Inactive IndicationsKidney NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A